Clark Kyle sold $2.1M of BETA (indirect holdings)

BETA Technologies (NYSE:BETA) reported Q2 progress on FAA-related testing for its CX300 and said H500A certification has not delayed the CX300 program. Backlog ended at 1,001 aircraft and $3.9B, targeting $4B year-end. It cited eIPP organ transport with United Therapeutics, 138 charging sites, and Q3 guidance of $8M-$12M revenue and adj. EBITDA of -$115M to -$125M.

BETA Technologies reported a Q2 2026 net loss of $148.8 million, versus a $80.4 million loss a year earlier, on revenue of $14.7 million up from $6.0 million. Operating expenses rose to $166.1 million, including higher R&D. Cash was about $1.48 billion. BETA raised FY revenue guidance to $42-$50 million and expects adjusted EBITDA loss of $400-$445 million.

BETA Technologies’ Q2 2026 earnings call reported revenue of $14.7 million, up 146% year over year, driven by its Electrified Powertrain Flight Demonstration program and charger deliveries. Adjusted EBITDA was -$109.8 million and net loss -$148.8 million. Full-year revenue guidance was raised to $42 million to $50 million; cash was $1.5 billion. The company discussed H500A certification execution risk and MV250 military variant progress.

Beta Technologies (BETA) reported Q2 2026 revenue of $14.7 million, up 146% year over year and above guidance, driven by EPFD program and charger deliveries. Backlog was 1,001 aircraft worth $3.9 billion. Adjusted EBITDA was -$110 million, with full-year guidance widened to -$400 million to -$445 million. Certification and cash burn remain key risks.

BETA Technologies shares fell 4.5% in pre-open trading after the company reported Q2 2026 results before the market open. Analysts expected a 46-cent per-share loss versus a 53-cent loss in Q1. The article cites prior Q1 misses and ongoing cash burn, plus a $39 million to $43 million full-year 2026 revenue guide and an SEC Form 8-K.

BETA Technologies reported Q2 2026 revenue of $14.7M, up from $6.0M a year earlier, with a net loss of $148.8M and adjusted EBITDA loss of $109.8M. Cash and cash equivalents were $1.479B at June 30, 2026. Full-year 2026 guidance was updated to revenue of $42–$50M and adjusted EBITDA of ($400)–($445) million.